Treatment of interleukin-1 receptor antagonist in combination with methotrexate (MTX) in rheumatoid arthritis (RA) patients.

被引：0
|
作者：
Cohen, S
Hurd, E
Cush, JJ
Schiff, MH
Weinblatt, ME
Moreland, IW
Bear, M
Rich, W
McCabe, DP
机构：
来源：
ARTHRITIS AND RHEUMATISM | 1999年 / 42卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1217
引用
收藏
页码：S273 / S273
页数：1
相关论文
共 50 条
  • [21] Clinical experience with interleukin-1 receptor antagonist in rheumatoid arthritis
    Bresnihan, B
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2001, 7 (03) : S12 - S16
  • [22] Treatment with recombinant human interleukin-1 receptor antagonist (rhIL-1ra) may reduce synovial infiltration in rheumatoid arthritis (RA).
    Cunnane, G
    Madigan, A
    FitzGerald, O
    Bresnihan, B
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1307 - 1307
  • [23] Pharmacokinetics (PK) of etanercept are unaltered by concurrent administration of methotrexate (MTX) in rheumatoid arthritis (RA) patients.
    Zhou, HH
    Buckwalter, M
    Mayer, P
    Raible, D
    Wajdula, J
    Fatenejad, S
    Sanda, M
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S139 - S139
  • [24] Treatment of rheumatoid arthritis with interleukin 1 receptor antagonist
    Bresnihan, B
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 : 96 - 98
  • [25] THE EFFECTS OF METHOTREXATE ON INTERLEUKIN-1 IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    CHANG, DM
    WEINBLATT, ME
    SCHUR, PH
    [J]. JOURNAL OF RHEUMATOLOGY, 1992, 19 (11) : 1678 - 1682
  • [26] Interleukin-1, interleukin-1 receptor antagonist and macrophage populations in rheumatoid arthritis synovial membrane
    Cauli, A
    Yanni, G
    Panayi, GS
    [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (09): : 935 - 940
  • [27] The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis
    Cunnane, G
    Madigan, A
    Murphy, E
    FitzGerald, O
    Bresnihan, B
    [J]. RHEUMATOLOGY, 2001, 40 (01) : 62 - 69
  • [28] The pharmacokinetics of interleukin-1 receptor antagonist in Chinese subjects with rheumatoid arthritis
    Chang, DM
    Chang, SY
    Yeh, MK
    Lai, JH
    [J]. PHARMACOLOGICAL RESEARCH, 2004, 50 (03) : 371 - 376
  • [29] Treatment of active rheumatoid arthritis (RA) with combination therapy by adding leflunomide (LEF) in patients with an inadeguate response to methotrexate (mtx)
    Pisoni, L
    Schito, E
    De Lucia, O
    Murgo, A
    Zeni, S
    Paresce, E
    Fantini, F
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 457 - 457
  • [30] METHOTREXATE (MTX) METABOLISM IN RHEUMATOID-ARTHRITIS (RA)
    GALIVAN, J
    KAMEN, B
    KREMER, JM
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (02) : 194 - 194
12345